
The US fertility clinic Oma Fertility has announced a partnership with the digital pharmacy service Alto to offer prescription delivery and telehealth support.
Through the partnership, patients will benefit from prescription delivery and pharmacist access through the Alto app.
The two companies say the partnership will ensure people will receive their prescription medications in a timely manner and with on-demand support from pharmacists to answer any questions or concerns about dosage, application, side effects and more.
“We are honoured to have been chosen as Oma’s pharmacy partner,” said Caitrin Best, VP and GM of Fertility at Alto Pharmacy.
“We are committed to furthering Oma’s mission of democratising fertility care by lowering the cost of fertility medication and supporting individuals through what can be a strict and intimidating medication regimen, especially when injections are involved.
“We are fully aligned in our approach of putting patients first and providing them with a comprehensive and positive care experience.”
Sahil Gupta, Oma Fertility co-founder and CCO, said: “We are so thrilled to have Alto as our pharmacy partner. They are raising the bar on what people can expect from their pharmacy, just as we’re providing a better, more personalised experience for fertility care.
“The fertility journey is a highly sensitive and critical time for many families, and working with Alto adds an important layer of support for all the families we serve.
“Our shared patient-first approach and emphasis on education ensures our patients feel informed and confident about the care they’re receiving, both inside and outside the clinic.”
Oma clinics aims to offer patients care advocates and education and prioritise doctor-patient relationships.
The partnership with Alto will ensure Oma’s patients will also have fair pricing and comprehensive care when it comes to receiving and administering necessary fertility medications, the clinic’s co-founder added.
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.






